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Exoenzyme S (ExoS), an ADP-ribosylating enzyme produced by the opportunistic pathogen Pseudomonas
aeruginosa, is directly translocated into eukaryotic cells by bacterial contact. Within the cell, ExoS ADPribosylates the cell signaling protein Ras and causes inhibition of DNA synthesis and alterations in cytoskeletal
structure. To further understand the interrelationship of the different cellular effects of ExoS, functional
analyses were performed on HT-29 epithelial cells after exposure to ExoS-producing P. aeruginosa 388 and the
non-ExoS-producing strain 388DS. Two different mechanisms of morphological alteration were identified: (i)
a more-transient and less-severe cell rounding caused by the non-ExoS-producing strain 388DS and (ii) a
more-severe, long-term cell rounding caused by ExoS-producing strain 388. Long-term effects of ExoS on cell
morphology occurred in conjunction with ExoS-mediated inhibition of DNA synthesis and the ADP-ribosylation of Ras. ExoS was also found to cause alterations in HT-29 cell function, leading to the loss of cell adhesion
and microvillus effacement. Nonadherent ExoS-treated cells remained viable but had a high proportion of
modified Ras. While microvillus effacement was detected in both 388- and 388DS-treated cells, effacement was
more prevalent and rapid in cells exposed to strain 388. We conclude from these studies that ExoS can have
multiple effects on epithelial cell function, with more severe cellular alterations associated with the enzymatic
modification of Ras. The finding that ExoS had greater effects on cell growth and adherence than on cell
viability suggests that ExoS may contribute to the P. aeruginosa infectious process by rendering cells nonfunctional.

Pseudomonas aeruginosa is an opportunistic pathogen which
affects compromised hosts such as individuals with cystic fibrosis, neutropenia, leukemia, and extensive wounds or burns. A
number of proteins produced by P. aeruginosa contribute to its
virulence, including exotoxin A, elastase, and phospholipase C,
each through characterized mechanisms of action. Less is
known about the cellular effects of exoenzyme S (ExoS), an
ADP-ribosylating enzyme known to contribute to P. aeruginosa
virulence by causing increased tissue damage and bacterial
dissemination (14). Difficulties in elucidating the cellular effects of ExoS relate to its type III mechanism of secretion from
P. aeruginosa, which requires direct contact between the bacterium and the target cell for the translocation of ExoS (34).
ExoS was first identified in P. aeruginosa 388 culture supernatants as an aggregate of two proteins: 49-kDa ExoS and
53-kDa ExoT (20, 23). These immunologically cross-reactive
proteins (14) were subsequently found to be encoded by separate, coregulated genes, with ExoT having 75% amino acid
identity with ExoS, but only 0.2% of the catalytic activity (33).
The integral relationship between ExoS function and the eukaryotic cell environment was first indicated by the requirement of a eukaryotic cofactor, 14-3-3 proteins, for ExoS ADPribosyltransferase (ADPRT) activity (4). In vitro analyses
identified multiple, functionally diverse proteins in mammalian
cell lysates as substrates for ExoS ADPRT activity. Preferred

substrates include specific low-molecular-mass GTP-binding
(LMMG) proteins in the Ras superfamily, including Ras (3, 5),
and the cytoskeletal protein vimentin (2).
Recognition of the requirement of bacterial contact for the
induction and delivery of ExoS into eukaryotic cells led to the
development of model systems which allowed bacterial translocation of ExoS and yet the differentiation of the cellular
effects of ExoS from those of other Pseudomonas factors. The
model system adapted by our laboratory used the prototype P.
aeruginosa ExoS-producing strain 388 to translocate ExoS, differentiating the effects of ExoS from those of other strain 388
factors in comparative studies with the isogenic non-ExoSproducing strain 388DS (25). This system allowed the identification of inhibitory effects of ExoS production on DNA synthesis and cellular viability, thus confirming a toxic effect of
ExoS on cell function (25). Later studies with this system identified Ras as an in vivo substrate of ExoS and found the efficiency of ADP-ribosylation of Ras to directly correlate with the
inhibition of cellular DNA synthesis, suggesting a cause-andeffect relationship (22). In a different model system with the
Yersinia type III secretory apparatus to translocate recombinant ExoS, ExoS expression was found to cause disruption of
the actin cytoskeleton (7). In these latter studies, although
more severe cell rounding was detected upon the translocation
of wild-type ExoS, cell rounding was also caused by a mutated
form of ExoS having a .2,000-fold-reduced ADPRT activity,
thus indicating that cytoskeletal alterations could occur independently of this enzymatic activity.
The multiple and diverse effects of ExoS on cell function can
be explained, to some extent, by its multidomain structure,
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which includes an amino-terminal domain possessing aggregation properties and required for ExoS secretion and a carboxyterminal domain having ADPRT enzymatic activity (17, 34).
Further diversity in the cellular effects of ExoS may also relate
to Ras functioning as an in vivo substrate of ExoS and the
potential of Ras to play a pivotal role in multiple signal transduction pathways. The purpose of the studies described here
was to further characterize and define the cellular effects of
ExoS upon its translocation into human epithelial cells via the
P. aeruginosa type III secretory process. The studies identified
additional effects of ExoS on cell adherence and microvillus
effacement and distinguished two mechanisms by which P.
aeruginosa 388 can cause alterations in HT-29 cell morphology:
an ExoS-dependent mechanism and an ExoS-independent
mechanism. More-severe or long-term effects of ExoS on cell
function consistently correlate with the ADP-ribosylation of
Ras, suggesting a role of ExoS enzymatic activity in permanent
alterations of ExoS in cell function.
MATERIALS AND METHODS
Bacterial strains and culture conditions. P. aeruginosa strains used in this
study include the parental strain 388 (1); strain 388DexoS, which lacks ExoS
production due to an allelic exchange of the majority of the structural gene with
a tetracycline gene cartridge (19); strain 388popD::Tc*, which lacks production of
the PopD translocation protein due to the insertion of the omega cartridge
encoding tetracycline resistance (31); and strain exs1::Tn1, which has a Tn1
insertion in the pscC type III secretory gene (34). Strain 388DS complementation
studies were performed by using a two-step cloning strategy to construct a
gentamicin-resistant plasmid containing the exoS structural gene. First, a 1.7-kb
PstI/BamHI fragment containing the exoS structural gene was isolated from
plasmid pUCPexoS (21, 34) by using the HindIII site within the multiple cloning
site of pUCPexoS and the BamHI site downstream of the exoS structural gene.
The 1.7-kb HindIII/BamHI fragment was then cloned into the broad-host-range
vector pCP13 (6) digested with HindIII and BamHI. Ligation products were
transformed into Escherichia coli JM109, and the exoS-containing pCP13 vector
(pCP13exoS) was confirmed by restriction analyses. Second, a 1.6-kb HindIII
fragment containing the gentamicin resistance cartridge from pGmV1 (29) was
cloned into the HindIII site of pCP13exoS to yield pCP13exoSGm. Plasmid DNA
isolated from gentamicin-resistant E. coli transformants was confirmed by restriction analyses and then transformed by triparental mating (12) into strain
388DS. Gentamicin-resistant 388DS clones were selected and maintained by
using 250 to 300 mg of gentamicin per ml.
Bacteria were grown and prepared for coculture with HT-29 cells as previously
described (22, 25), except when eukaryotic cell induction of ExoS effects on cell
function were assessed. In these experiments bacteria were grown in non-ExoSinducing medium containing unchelated Trypticase soy broth, 1% glycerol, and
100 mM monosodium glutamate (TSB). ExoS ADPRT activity in bacterial culture supernatants was quantified as previously described (25) and reported as
femtomoles of ADP-ribose transferred per minute per milliliter of culture supernatant. For coculture studies, bacteria were diluted to the indicated concentration in McCoy 5A tissue culture medium containing 0.6% bovine serum
albumin (McCoy-BSA) (Gibco-BRL, Gaithersburg, Md.). These suspensions
were subsequently plated to confirm the bacterial concentration and to determine the multiplicity of infection (MOI) in HT-29 cell coculture studies. MOIs
of 10:1 to 100:1 bacterial versus eukaryotic cells were used in these studies, as
specifically indicated, with this range previously found to be optimal for detection
of effects of ExoS on cell function and Ras modification (22, 25).
HT-29 cell culture. HT-29 cells, a human carcinoma cell line obtained from the
American Type Culture Collection (ATCC), were cultured as specified by ATCC
in McCoy 5A medium supplemented with 10% fetal bovine serum (McCoy-FBS)
at 37°C in 5% CO2–95% air. Cells were split 1:6 and passaged as the culture
reached confluence. For coculture with bacteria, cells were detached from the
growth surface with 0.25% trypsin–1 mM EDTA (trypsin-EDTA) (Gibco-BRL),
resuspended in McCoy-FBS, counted, diluted to the appropriate density in
McCoy-FBS, and then seeded in 48- or 6-well plates (Costar, Cambridge, Mass.)
and cultured for 48 h. Bacteria were cocultured with HT-29 cell monolayers for
1 to 4 h, and HT-29 cells were processed and assayed in cell function assays
described below.
Examination of bacterial effects on HT-29 cell function. In all experiments,
control and experimental cells were identically treated, except that in controls,
coculture medium did not contain bacteria.
(i) Quantification of DNA synthesis. After the coculture period, bacteria were
removed from HT-29 cell monolayers; monolayers were then washed with McCoy-FBS containing 200 mg of gentamicin/ml and 100 mg of ciprofloxacin/ml
(McCoy-FBS-GC), pulsed in McCoy-FBS-GC, and analyzed for [3H]thymidine
incorporation after 20 h, as previously described (25).
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(ii) Immunoprecipitation, detection, and quantification of Ras proteins. Ras
was immunoprecipitated from cells after coculture with bacteria by using monoclonal Y13-259 Ras antibody (ATCC), rabbit anti-rat immunoglobulin G (Sigma), and protein A-Sepharose (Sigma), as previously described (22). Proteins
were resolved on sodium dodecyl sulfate (SDS)–15% polyacrylamide gels, and
Ras immunoblots were developed by using pan-Ras OP22 antibody (Oncogene
Research, Cambridge, Mass.) and enhanced chemiluminescence (Amersham).
(iii) Examination of cell morphology. Long-term effects of strain 388 and
mutant strains on cell morphology were assessed by phase-contrast microscopy in
conjunction with DNA synthesis assays at the end of the 20-h pulse period. For
video time-lapse microscopy, cells were grown and cultured with bacteria in
25-cm2 flasks. After the removal of bacteria and the addition of medium containing antibiotics, culture vessels were placed in an incubation chamber
mounted on the stage of an adapted Zeiss ICM-405 inverted phase-contrast
microscope. The temperature in the chamber was maintained at 37°C, and the
atmosphere contained 5% CO2–95% air. Selected fields of ca. 100 cells were
examined by using a 403 objective lens, and images were captured by using a
Hitachi KP-M1U charge-coupled device camera. Recordings were made at a
temporal ratio of 20:1 by using a time-lapse video recorder.
(iv) Analysis of cellular adherence. After a 3-h coculture period, bacteria were
removed, HT-29 cell monolayers were washed three times with McCoy-FBS-GC,
and then cells were detached from the growth surface with trypsin-EDTA.
Detached cells were resuspended in the original volume of McCoy-FBS-GC,
replated, and allowed to grow for 20 h. At this time, nonadherent cells were
recovered and saved and adherent cells were detached with trypsin-EDTA. Each
cell population was assayed for cell number, viability, and necrosis by trypan blue
exclusion, as previously described (25), and for DNA synthesis, Ras modification,
and apoptosis.
(v) Analysis of apoptosis. To quantify internucleosomal fragmentation, 106
HT-29 cells, treated as indicated, were lysed, and DNA fragmentation was
analyzed in a Cell Death Detection enzyme-linked immunosorbent assay
(ELISA; Boehringer Mannheim, Indianapolis, Ind.). The relative amount of
apoptosis was determined by calculating an enrichment factor in which the
absorbance of the sample (after subtracting the background level) was divided by
the absorbance of the control.
Scanning electron microscopy. Bacterial strains 388, 388DS, DPopD, and
DPscC (108 CFU/ml) or no bacteria were cultured for 1, 2, or 3 h with HT-29 cell
monolayers grown on 12-mm glass coverslips. Bacteria were removed, and cells
were washed twice with McCoy-BSA, fixed in situ in 2% glutaraldehyde in 0.1 M
cacodylate buffer (pH 7.4), rinsed, postfixed in 1% osmium in 0.1 M cacodylate
buffer, and then dehydrated in a graded series of ethanol mixtures and treated
with hexamethyldisilane. After they were dried, coverslips were coated with gold
and examined by using a JEOL JSEM-LV5410 scanning electron microscope.

RESULTS
Identification of ExoS-specific effects on HT-29 cell DNA
synthesis and morphology. Identifying the effects of ExoS on
cell function has been complicated by its type III mechanism of
secretion and the requirement for bacterial contact in the delivery of ExoS into target cells. To differentiate the cellular
effects of ExoS from those of other bacterial factors during
coculture studies, P. aeruginosa strains having mutations in
ExoS production or components of the type III secretory process were compared for their effects on DNA synthesis and
cellular morphology. The specific strains examined included
the following: (i) ExoS-producing strain 388; (ii) the non-ExoSproducing isogenic strain 388DS; (iii) strain 388DS complemented with a pCP13exoSGm plasmid containing the exoS
structural gene (DS1S); (iv) strain 388popD::Tc*, which lacks
expression of PopD, a homolog of Yersinia YopD involved in
type III translocation (DPopD) (36); and (v) strain 388
exs1::Tn1, which lacks production of PscC, a homolog of the
Yersinia YscC protein involved in type III secretion (DPscC)
(34). The differential effect of each of the 388 strains on HT-29
epithelial cell function was examined relative to the induction
or noninduction of ExoS production prior to the coculture
period. High levels of ExoS production were confirmed in
culture supernatants of strains 388 and DS1S grown in
TSBD-N inducing medium prior to coculture with HT-29 cells
(46.6 and 36.9 fmol of ADP-ribose transferred min21 ml21,
respectively), but not in the respective strains grown in TSB
noninducing medium (,0.3 fmol of ADP-ribose transferred
min21 ml21). Regardless of the bacterial preculture condi-
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FIG. 1. ExoS-specific effect on cell proliferation and Ras modification. DNA
synthesis was examined in HT-29 cells, seeded at 105 cells/well, cultured for 48 h,
and then cocultured with 107 CFU of 388, 388DS (DS), 388DS complemented
with ExoS (DS1S), DPopD, or DPscC bacteria per ml (MOI of 10:1). Bacteria
were either induced or noninduced for ExoS production in TSBD-N or TSB
media, respectively, prior to coculture with HT-29 cells. After 4 h, bacteria were
removed and replaced with medium containing [3H]thymidine and antibiotics to
inhibit further bacterial growth, and DNA synthesis was assayed after 20 h. The
means and standard deviations of assays performed in triplicate are indicated,
and the results are expressed as percentages of non-bacterium-treated monolayer DNA synthesis. (Inset) To analyze for Ras modification, cells were cocultured in a manner identical to that described above, the culture supernatants
were removed, the cells were lysed, and Ras was immunoprecipitated by using
Ras monoclonal Y13-259 antibody. Proteins were resolved by sodium dodecyl
sulfate-polyacrylamide gel electrophoresis, and Ras immunoblots were developed by using pan-Ras OP22 antibody and detected by using enhanced chemiluminescence. The mobility of unmodified Ras (U) and modified Ras (M) are
indicated.

tions, the same pattern of DNA synthesis inhibition by the
bacterial strains was detected, indicating that contact with
HT-29 cells is sufficient for the induction of ExoS effects on
DNA synthesis (Fig. 1). Strains 388 and DS1S were found to
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cause the greatest (and comparable) levels of inhibition of
[3H]thymidine incorporation (;80%), which correlated with
an equally efficient shift in Ras mobility (Fig. 1, inset). Less
inhibition of DNA synthesis was caused by strains 388DS,
DPopD, and DPscC (;50%), the comparable inhibition by
these mutants reflecting an undefined bacterial factor not related to ExoS production nor the expression of the respective
type III secretory products. The 30% greater inhibition of
DNA synthesis and the modification of Ras by strains 388 and
DS1S, when compared to that of 388DS, identifies an ExoSspecific effect. The lack of this 30% greater inhibition in the
type III secretory mutants also confirms the requirement of the
P. aeruginosa PopD translocation and PscC secretion proteins
for ExoS effects on DNA synthesis. When HT-29 cell morphological alterations were examined 20 h after exposure to bacteria, at the end of the DNA pulse period, severe rounding was
detected in HT-29 cells exposed to strains 388 and DS1S but
not in HT-29 cells exposed to the other bacterial strains (Fig.
2). We conclude from these studies that ExoS production by
strain 388 is directly associated with increased inhibition of
DNA synthesis, Ras modification, and long-term alterations in
cell morphology.
Examination of the temporal course of morphological
changes in HT-29 cells caused by strain 388. Further understanding of the effects of ExoS on HT-29 cell morphology was
gained by using time-lapse microscopy. In these studies, HT-29
cells were cocultured with strain 388 or 388DS for 3 h, and then
bacteria were removed and the cells were treated with antibiotics to inhibit further bacterial growth and monitored for
morphological alterations over a 24-h period. Cell rounding
was evident 3 h after exposure to both strains 388 and 388DS
compared to non-bacterium-treated control cells, but the
rounding caused by strain 388 was more severe (Fig. 3). The
differential effects of strains 388 and 388DS on cell morphology
became more evident after 24 h, at which time cells exposed to
strain 388DS regained normal morphology, while those exposed to strain 388 remained rounded. These studies draw
attention to different mechanisms by which strain 388 can
cause morphological alterations. One mechanism, which appears less severe and more transient, is recognized in strain
388DS and occurs in the absence of enzymatically active ExoS.

FIG. 2. ExoS-specific effects on HT-29 cell morphology. HT-29 cells were cocultured with strain 388, 388DS (DS), DS1S, DPopD, or DPscC and examined for
morphological alterations by phase-contrast microscopy after 20 h. Studies were performed in conjunction with the DNA synthesis assays shown in Fig. 1.
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FIG. 3. Time-lapse video analysis of effects of strains 388 and 388DS on
HT-29 cell morphology. HT-29 cells were seeded at 5 3 105 cells/ml in 25-cm2
tissue culture flasks and grown overnight to ;30% confluency. Cells were then
cocultured with 108 CFU of 388 or 388DS bacteria per ml (MOI of 20:1) or no
bacteria (0) for 3 h. Bacteria were removed and replaced with medium containing antibiotics. A single field of each culture was videotaped for 24 h by using a
Zeiss ICM-405 inverted-phase microscope equipped with a warm stage heaterrecirculator device and maintained at 37°C in a 5% CO2–95% air atmosphere.
Illustrative images obtained in a single field were captured and recorded at a
temporal ratio of 20:1. Magnification, 340.

A second, which causes a long-term alteration in cellular morphology, occurs in the presence of enzymatically active ExoS.
Effects of ExoS production on cell adherence. Functional
consequences of differential effects of strains 388 and 388DS on
cellular morphology were examined by using cell re-adherence
assays. Since minimal loss of HT-29 cell adherence to cell
matrix was observed in association with cell rounding after the
3-h coculture period with either strain 388 or strain 388DS,
adherence was functionally evaluated in replating assays where
HT-29 cells were passaged after a 3-h exposure to bacteria.
Cell viability and the efficiency of re-adherence were then
examined 20 h later. As shown in Fig. 4, more than 95% of
HT-29 cells exposed to strain 388DS were able to re-adhere at
20 h. This compared to only 27% of the 388-treated cells being
able to re-adhere, with 65% of the 388-treated cells remaining
viable but nonadherent. DNA synthesis assays detected the
relative rate of [3H]thymidine incorporation in cells exposed to
strain 388 to be approximately twofold lower than in cells
exposed to strain 388DS, regardless of the re-adherence. When
the eventual fate of the 388-treated cells was assessed, the
number of necrotic cells was two- to threefold higher after
treatment with strain 388 compared to treatment with strain
388DS or with no bacteria, averaging 13.2 6 3.6% at 24 h and
26.4 6 6.6% at 48 h. A similar relative increase in the number
of apoptotic cells was detected in 388-treated cells with an
ELISA to quantify nucleosomal DNA fragments present in the
cell lysates. Levels of apoptosis in cells exposed to strains 388
and 388DS were increased by factors of 7.4 6 1.1 and 2.6 6 1.1,
respectively, compared to non-bacterium-treated control cells.
A DNA ladder, characteristic of apoptosis, was detected in
HT-29 cells exposed to strain 388 but not in cells exposed to
strain 388DS or to no bacteria (not shown). While we cannot
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FIG. 4. Effect of ExoS production on HT-29 cell re-adherence. HT-29 cells
were cocultured with 108 CFU of bacteria per ml for 3 h (MOI of 30:1); bacteria
were then removed, and cells were detached by trypsin-EDTA treatment and
reseeded in culture wells. At 20 h, adherent and nonadherent cells were harvested separately, cell viability and numbers were assessed by trypan blue staining, and DNA synthesis was assayed as described in Fig. 1. Viability is expressed
as the percentage of total adherent plus nonadherent cells, and the means and
standard errors of three independent assays are shown. DNA synthesis, indicated
in brackets above bars, is reported as the disintegrations per minute per 1,000
cells in the respective adherent or nonadherent populations. Results of one of
three independent DNA assays are shown, and the mean of assays performed in
triplicate is represented.

determine from our studies whether the observed decrease in
cell viability after exposure to strain 388 was due to loss of
adherence or a direct effect of ExoS, recent studies have found
the ADPRT domain of ExoS to be cytotoxic when transiently
expressed in CHO and Vero cells (26), implying that both
mechanisms are possible. The finding, however, that cell viability was maintained in a high percentage of 388-treated cells
20 h after exposure to bacteria indicates that the immediate
effect of ExoS on HT-29 cells was not on viability but on cell
morphology, adherence, and DNA synthesis.
When alterations in cell adherence were related to Ras
modification, Ras was found to be more efficiently modified in
nonadherent than in adherent 388-treated cells. In time course
studies comparing Ras modification and loss of adherence to
increasing time of exposure to bacteria, Ras modification was
found to precede the loss of re-adherence (Fig. 5). In the
adherent 388-treated HT-29 cell population, levels of unmodified Ras decreased with increasing time, a finding which corresponded to an increased proportion of modified Ras in the
nonadherent 388-treated HT-29 cells. These studies imply that
the ADP-ribosylation of Ras by ExoS is coordinated with the
loss of HT-29 cell matrix adherence.
Examination of HT-29 cellular alterations associated with
ExoS production and type III secretory processes. Scanning
electron microscopy was used to compare the progression of
cellular changes after a 1-, 2-, or 3-h exposure of HT-29 cells to
strains 388, 388DS, DPopD, and DPscC. As shown in Fig. 6A
and B, cell rounding was evident in HT-29 cells after a 1- or 3-h
exposure to strain 388 and, in many instances, rounded cells
showed a severe loss of cell surface microvilli. Bacteria ap-
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FIG. 5. Association of Ras modification with loss of adherence after exposure to ExoS-producing bacteria. HT-29 cells were cocultured with no bacteria
(0) or with 108 CFU of strain 388 or strain 388DS (DS) bacteria per ml for 2, 4,
or 6 h (MOI of 95:1). Bacteria were removed, and cells were reseeded in culture
wells; adherent and nonadherent cells were then harvested after 20 h as described for Fig. 4. Ras was immunoprecipitated from cell lysates, and Ras modification was analyzed as described in Fig. 1 in adherent cells treated with no
bacteria or with strain 388DS and in both adherent and nonadherent (indicated
by an asterisk) cells treated with strain 388. The percentage of adherent or
nonadherent viable cells in each population is indicated below the respective Ras
modification patterns. The mobility of unmodified Ras (u) and modified Ras (m)
is indicated.

peared to remain securely attached to HT-29 cells in the absence of microvilli, and no cellular structures, such as pedestals, were evident underneath the bacteria. While cell rounding
and loss of microvilli were also apparent in cells exposed to
strain 388DS, both events occurred more slowly, with loss of
microvilli detected only after 3 h and three- to fourfold less
frequently than was observed with strain 388. Cell rounding
was also detected in HT-29 cells after coculture with strains
DPopD and DPscC; however, no notable loss of microvilli was
observed during the 3-h exposure to bacteria. The finding that
ExoS facilitates but is not required for cell rounding or effacement draws attention to the ability of non-ExoS-related bacterial factors to initiate alterations in cell structure and loss of
microvilli. The inability of PopD and PscC mutant strains to
cause effacement within the same time frame also implies the
role of the type III secretory process in cellular alterations
leading to the loss of HT-29 cell surface microvilli.
DISCUSSION
As an understanding of ExoS and its regulatory and secretory processes unfolds, it becomes increasingly evident that
ExoS functions in a manner distinctly different from other
known P. aeruginosa virulence factors. ExoS is part of a complex regulon that includes a type III secretory process and
responds to eukaryotic cell contact. The contact-mediated
translocation of ExoS into target cells, as with other type III
secreted proteins, allows ExoS direct access to eukaryotic cell
signaling processes. Current data support that ExoS can have
multiple effects on cell function, which likely relates to independent, but coordinated, activities of the amino- and carboxyterminal domains of ExoS, as well as to its enzymatic modification of cellular Ras, a protein integral to cell signaling
through multiple pathways.
To gain a more precise understanding of the interrelationship of cellular processes involved in the effects of ExoS on cell
function, the differential effects of the ExoS-producing strain
388 on HT-29 epithelial cell function were compared to those
of 388 mutant strains lacking production of ExoS or defined
components of the type III secretory system. A 30% greater
inhibition of DNA synthesis was identified as being a direct
result of the production and type III-mediated translocation of
ExoS. This occurred in addition to an approximate 50% inhibition of HT-29 cell DNA synthesis caused by non-ExoS- or
non-type III-related bacterial factors produced by strain 388
during the coculture period. While the bacterial factors responsible for the non-ExoS-related inhibition have not been
specifically investigated, this inhibition appears to differ from
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that of ExoS in becoming more pronounced upon prolonged
exposure to bacteria. Previous studies found the differential
effects of ExoS production on DNA synthesis to be initiated
relatively early in the coculture period, detectable after a 0.5-h
exposure to bacteria, but becoming optimal within a 3- to 4-h
exposure (22, 25). Other, more generalized effects on cell function, including inhibition of protein synthesis, decreased cell
viability, as well as increased inhibition of DNA synthesis,
become apparent upon prolonged coculture times or exposure
to higher concentrations of bacteria. The complex and multiple
effects of strain 388 on cell function reflect the multifactorial
nature of P. aeruginosa virulence. The effects of ExoS on Ras
modification and DNA synthesis, however, appear to precede
other effects on cell function, implying a role in early stages of
the P. aeruginosa infectious process.
Consistent with common or coordinated signaling events
being involved in the effects of ExoS on DNA synthesis and
cytoskeletal alterations, both events were initiated early in the
coculture period, required an intact type III secretory apparatus, and were associated with the ADP-ribosylation of Ras.
Time-lapse video studies revealed that strain 388 could cause
alterations in cell morphology by an ExoS-independent mechanism, as well as by an ExoS-dependent mechanism. Longterm alterations in cell morphology required ExoS production,
while short-term alterations in morphology were apparent in
strain 388DS-treated HT-29 cells, and both appeared to be
facilitated by an intact type III secretory process. Strain 388DS
produces two known type III effector proteins, ExoT and
ExoY, both of which have been found to cause cell rounding
(30, 37). It is notable that the less severe, short-term cell
rounding detected in HT-29 cells cocultured with strain 388DS
resembled that of the less severe cell rounding observed by
Frithz-Lindsten et al. (7) when the effects of wild-type ExoS
and of the E381A enzymatic mutant form of ExoS on HeLa
cells were compared. Although the effects of an ADPRT inactive form of ExoS were not directly examined in our studies,
strain 388DS produces ExoT, which is highly homologous to
ExoS, yet it has ,0.2% of the catalytic activity. Thus, it is
possible that ExoT, produced by strain 388DS, may be functioning in a manner similar to that of E381A mutant ExoS in
causing the less-severe, short-term cell rounding. The aminoterminal domain of ExoS shows homology with the Yersinia
virulence factor YopE (35), a Yersinia cytotoxin that disrupts
cytoskeletal structure by an as-yet-undefined mechanism (28).
Similarly, the amino-terminal domain of SptP, a virulence factor secreted by Salmonella typhimurium via the type III process, has been found to share homology with YopE and ExoS
and cause a similar disruption of actin cytoskeleton structure
(8). The seemingly comparable alteration in cell morphology
caused by type III effector proteins, independent of other identified enzymatic activities, suggests that a transient alteration in
host cytoskeletal structure may be a common feature of proteins translocated by the type III secretory process.
Functional consequences of differences in the effects of
strains 388 and 388DS on HT-29 cell morphology became more
evident in cellular adherence analyses. Although neither strain
388 nor strain 388DS caused significant loss of HT-29 cell
adherence during the coculture period, when cells were passaged after exposure to bacteria and assayed for re-adherence,
less than one-third of strain 388-treated cells were able to
re-adhere to tissue culture wells. The ADP-ribosylation of Ras
by ExoS appeared to precede and increase with the loss of
re-adherence, suggesting coordination between loss of adherence and Ras modification. These studies indicate that longterm alterations in cell morphology caused by strain 388 can be
functionally differentiated from the short-term alterations of
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FIG. 6. Scanning electron microscopy of HT-29 cells cocultured with ExoS-producing bacteria, non-ExoS-producing bacteria, or type III secretory mutant bacteria.
Strains 388, 388DS, DPopD, and DPscC (MOI of ;30:1) were cocultured for 1, 2, or 3 h with HT-29 monolayers grown on 12-mm-diameter glass coverslips. Cells were
then washed, fixed in situ in 2% glutaraldehyde, postfixed in 1% osmium, dehydrated in a graded series of ethanol mixtures, and treated with hexamethyldisilane. After
cells were dried, the coverslips were coated with gold and examined by using a JEOL JSEM-LV5410 scanning electron microscope. Images representative of indicated
time points are shown, with each image at a 35,000 magnification. (A and B) Cells treated with strain 388 show cell rounding and loss of cell surface microvilli after
1 and 3 h of exposure to bacteria. (C and D) Cells treated with strain 388DS show cell rounding after 1 and 3 h, with microvillus effacement not evident until 3 h. (E
and F) Cells treated with strains DPopD and DPscC show cell rounding but no microvillus effacement after 3 h.

strain 388DS, based on their association with the disruption of
focal adhesion. Focal adhesion complexes play an integral role
in the transduction of cellular signals, and the formation of
stable focal adhesion complexes are linked to the actin cytoskeletal structure (38). The effects of ExoS on cell adherence
and cytoskeletal structure could therefore both be linked to an
interruption of actin polymerization. The previous finding that
ExoS can exert less-severe effects on cell morphology in an
ADPRT-independent manner (7), coupled with our observation that more-severe cytoskeletal alterations and loss of cell
matrix adherence occur in association with Ras modification, is
consistent with the multifunctional domain structure of ExoS,
with the amino-terminal YopE homologous region of ExoS
causing transient alterations in cytoskeletal structure that are

coordinated with more-severe cytoskeletal alterations caused
by the ADP-ribosylation of cellular proteins by the carboxyterminal domain.
In previous studies, the modification of Ras by ExoS was
found to correlate directly with inhibition of DNA synthesis
(22). Although a large number of Ras-effector interactions
have been identified (16), the best characterized of these, the
activation of Raf by interaction with Ras, induces the transfer
of a proliferative or differentiation signal to the nucleus. Recent in vitro and in vivo studies have found that the ADPribosylation of Ras by ExoS interferes with Raf activation (10,
32), thus providing a mechanism for the inhibitory effects of
ExoS on DNA synthesis and PC12 neurite outgrowth (9, 25). A
current understanding of cell signaling pathways finds that Ras
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can also affect cytoskeletal structure through indirect interactions with the Rho subfamily of LMMG proteins that regulate
actin polymerization. Rho, Rac, and Cdc42 play distinct roles
in actin rearrangement, forming stress fibers, lamellipodia, and
filopodia, respectively. These three proteins also form an interactive network, with Cdc42 able to activate Rac, and Rac
able to activate Rho, and all three can associate with integrinbased adhesion complexes (reviewed in references 11 and 13).
Ras, via its direct interaction with phophatidylinositol 3-kinase
(PI3K), can activate Rac and cause actin rearrangement (27).
The guanine nucleotide exchange factor Sos has also been
found to couple Ras with Rac in a PI3K-dependent manner
(24). Thus, it is possible that effects of ExoS on cytoskeletal
structure may result from the modification of Ras. An alternative explanation for the cytoskeletal effects of ExoS relates
to the potential diverse substrate specificity of ExoS and the
possibility that ExoS might directly modify or alter the function
of proteins, such as Rac, Cdc42, Rho, or the intermediate
filament vimentin, that affect cytoskeletal structure. Effects of
ExoS on cell morphology and adherence would thus appear to
be coordinated with Ras modification and the inhibition of
DNA synthesis but mediated by the modification of proteins in
alternative signal transduction pathways.
While many similarities are observed in eukaryotic cell functions altered by the type III secretory process of different
bacteria, each bacterium appears to manipulate eukaryotic
pathways in a slightly different manner which best enhances the
survival of the specific organism. P. aeruginosa, like enteropathogenic E. coli (EPEC), is predominantly an extracellular
organism, and both bacteria use type III secreted proteins to
mediate their infectious processes. Electron microscopy studies revealed that contact between EPEC and host epithelial
cells results in the effacement of microvilli from the surface of
cells and the production of a densely packed cytoskeletal structure forming a pedestal beneath the bacterium (18). Microvilli
effacement and pedestal formation were found to be associated
with the accumulation of cellular actin and to require the
EPEC type III secretory system (15). When the interaction of
the ExoS-producing strain 388 with HT-29 cells was examined
by scanning electron microscopy, microvillus effacement, similar to that observed for EPEC, was detected, often in conjunction with severe cell rounding. No pedestal-like structures,
however, were evident underneath strain 388 P. aeruginosa.
Some microvillus effacement was also apparent in HT-29 cells
exposed to strain 388DS, indicating that the process can occur
independently of ExoS production; however, effacement was
facilitated by ExoS production. Scanning electron microscopy
revealed minimal loss of microvilli in HT-29 cells treated with
strain 388 bacteria having mutations in their type III secretory
apparatus, indicating, as with EPEC, that the type III secretory
system facilitates the P. aeruginosa effacement process. Thus,
like other bacteria whose infectious process is mediated by the
type III secretory system, P. aeruginosa appears to have acquired a slightly different mechanism of manipulating eukaryotic cell function, but alterations in actin cytoskeletal structure
appear to be part of this mechanism.
The studies described here have increased the list of effects
that ExoS can have on cell function, providing further insight
into the complex effects of ExoS on eukaryotic cell signaling
processes. Although the coordinated activities of both enzymatic and nonenzymatic portions of ExoS cause alterations in
cell function, the direct association of the ADP-ribosylation of
Ras with effects of ExoS on DNA synthesis, cell adherence,
and long-term morphological alterations are consistent with
ExoS ADPRT activity contributing to the more-severe alterations in cell function. While different signaling pathways may

be involved in these cellular effects, a common signal leading to
an interruption of cell function appears to be delivered to
HT-29 epithelial cells. This becomes most apparent in functional analyses of HT-29 cell populations that lose adherence
after exposure to ExoS-producing bacteria. These cells have a
lower DNA proliferative index, lack functional focal adhesion
complexes and cytoskeletal structures required for the integration of cell signals, and have a high proportion of ADP-ribosylated Ras, and yet the majority of cells remain viable after
48 h. This indicates that the immediate outcome of exposure to
ExoS is not cell death but rather an inhibition of normal cellular processes required for growth and adherence. While the
effects of ExoS on cell viability can be observed upon moreprolonged exposure to bacteria (25), we hypothesize that the
initial role of ExoS in the P. aeruginosa infectious process is
one of cellular inactivation. ExoS production, in combination
with other P. aeruginosa virulence factors, then leads to the
eventual death of the target cell via necrotic and apoptotic
mechanisms. Relative to epithelial tissue, an interruption of
cell growth and adherence would result in increased bacterial
dissemination.
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